2021. RFLSP.Russian.Finnish.Life.Science.Industry.EN

1 PART 1: MARKET RESEARCH
1.1 Industry overview
1.1.1 Overview of the Russian pharmaceutical market
Today, the pharmaceutical industry in Russia is one of the drivers of innovative development
of the national economy and healthcare and has been demonstrating steady growth in recent
years. Even in 2020, which was extremely dramatic for the global economy, the Russian
pharmaceutical market experienced high sales dynamics.
According to DSM Group, 1 the Russian pharmaceutical market in the period from 2016 to 2019
grew annually by an average of 6.6% in ruble terms. At the same time, in 2020 the Russian
pharmaceutical market showed an increase of 9.8% instead of the projected 5-6%, the market
volume reached RUB 2,040 billion.
Pharmaceutical market dynamics, RUB bln
1 640 1 695
1 858
2 040
2017 2018 2019 2020
Source: DSM Group
The growth of the dollar and euro rates in March 2020 led to the fact that in dollar and euro
terms the market volume did not grow. So, in dollar terms in 2020, the volume amounted to
USD 29 billion, which is only 0.2% higher than in 2019. In euros, due to the higher growth of
the exchange rate – by 11%, the market dynamics turned out to be negative: -1.6%.
1
Hereinafter, the statistics of the pharmaceutical market of the Russian Federation is given according to the annual
analytical reports of the DSM Group agency for 2017-2020.
8
RUSSIAN-FINNISH LIFE SCIENCE INDUSTRY
Research and export directory